EYE AND ORBIT

Clinical trials for EYE AND ORBIT explained in plain language.

Never miss a new study

Get alerted when new EYE AND ORBIT trials appear

Sign up with your email to follow new studies for EYE AND ORBIT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug combo tested to fight tough brain cancer in seniors

Disease control Completed

This study tested whether adding the immunotherapy drug nivolumab after standard chemotherapy is safe and effective for older adults (65+) with a rare brain cancer called primary CNS lymphoma. The goal was to see if this extra treatment could help keep the cancer from coming back…

Matched conditions: EYE AND ORBIT

Phase: PHASE1 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

EYE AND ORBIT

Get alerted when new EYE AND ORBIT trials appear

New drug combo tested to fight tough brain cancer in seniors